Previous close | 233.23 |
Open | 233.00 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1200 |
Day's range | 232.18 - 233.93 |
52-week range | 156.72 - 234.68 |
Volume | |
Avg. volume | 1,263,643 |
Market cap | 66.703B |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | 43.26 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (0.98%) |
Ex-dividend date | 18 Jun 2024 |
1y target est | N/A |
QuidelOrtho's (QDEL) first-quarter results reflect growth in revenues, excluding the COVID-19 revenue impact.
Ashland (ASH) is set to sell its nutraceuticals business to Turnspire Capital Partners, with the deal expected to close in third-quarter 2024.
OPKO Health's (OPK) first-quarter results reflect soft performances despite robust RAYALDEE sales and strength in the Pharmaceuticals segment.